Acerca de

Anodyne will be attending the J.P. Morgan Healthcare Conference 2025, happening January 13-16 in San Francisco, California. This event brings together leaders from across the industry to discuss healthcare advancements and opportunities. 

​

Our HeroPatch™ platform, is a transdermal drug delivery technology aimed at providing convenient, patient-friendly treatment options. Our once-weekly GLP-1 patch highlights our work in addressing metabolic health challenges and the capabilities of the platform.

​

Jake Lombardo (CEO) and Konstantinos Tzortzakis (CBO) will also be present at the Biotech Showcase event, which runs alongside JPM 2025. We’re excited to connect with others, share our progress, and explore potential partnerships.

​

Connect with Us: If you’ll be attending, feel free to reach out to schedule a meeting or learn more about our work at partnering@theheropatch.com